migraine
-
Community
FDA approves new treatment for adults with migraine
The U.S. Food and Drug Administration has approved Ubrelvy (ubrogepant) tablets for the acute (immediate) treatment of migraine with or…
Read More » -
Community
FDA approves new treatment for migraines
Eli Lilly and Company (NYSE: LLY) announced that the U.S. Food and Drug Administration (FDA) has approved Emgality™ (galcanezumab-gnlm) 120…
Read More »
